ACA Portfolio, Winners and Losers Affordable Care Act (ObamaCare)

7/27/2019 ACA Portfolio, Winners and Losers Affordable Care Act (ObamaCare)

1/10

Stock Symbol Industry Portfolio % Dollar Amount # of shares Stock Price 01/02/2013 Current Price Return YTD Current $ Amount Assumptions

Insurance 10% $100,000.00 Portfolio Amount

WLP 3.33% $33,333.33 545.7323728 61.08$ 87.84$ 44% 47,937.13$

UNH 3.33% $33,333.33 607.3858115 54.88$ 73.98$ 35% 44,934.40$

CI 3.33% $33,333.33 616.1429452 54.10$ 81.30$ 50% 50,092.42$

Drug Distributors 20% $200,000.00

CVS 4.00% $40,000.00 815.9934721 49.02$ 58.50$ 19% 47,735.62$

WAG 4.00% $40,000.00 1056.524036 37.86$ 50.23$ 33% 53,069.20$

ABC 4.00% $40,000.00 917.6416609 43.59$ 58.18$ 33% 53,388.39$

MCK 4.00% $40,000.00 408.3716182 97.95$ 122.96$ 26% 50,213.37$

CAH 4.00% $40,000.00 963.6232233 41.51$ 50.21$ 21% 48,383.52$

Hospitals 20% $200,000.00

HCA 4.00% $40,000.00 1305.057096 30.65$ 38.74$ 26% 50,557.91$

CYH 4.00% $40,000.00 1267.427123 31.56$ 39.37$ 25% 49,898.61$

HMA 4.00% $40,000.00 4210.526316 9.50$ 12.88$ 36% 54,231.58$

VHS 4.00% $40,000.00 3189.792663 12.54$ 20.94$ 67% 66,794.26$

THC 4.00% $40,000.00 1205.908954 33.17$ 40.83$ 23% 49,237.26$

Pharmaceuticals 20% $200,000.00

ABT 4.00% $40,000.00 1238.390093 32.30$ 33.72$ 4% 41,758.51$

LLY 4.00% $40,000.00 800.9611534 49.94$ 52.09$ 4% 41,722.07$

MRK 4.00% $40,000.00 955.566173 41.86$ 47.49$ 13% 45,379.84$

PFE 4.00% $40,000.00 1566.784175 25.53$ 28.24$ 11% 44,245.99$

JNJ 4.00% $40,000.00 563.2216277 71.02$ 86.95$ 22% 48,972.12$

Medical Device 5% $50,000.00

ISRG 2.50% $25,000.00 49.35834156 506.50$ 385.17$ -24% 19,011.35$

MDT 2.50% $25,000.00 603.1363088 41.45$ 53.62$ 29% 32,340.17$

Biotechnology 20% $200,000.00

IBB 5.00% $50,000.00 356.353788 140.31$ 201.94$ 44% 71,962.08$

GILD 5.00% $50,000.00 672.8569506 74.31$ 60.98$ -18% 41,030.82$

CELG 5.00% $50,000.00 624.0639041 80.12$ 145.40$ 81% 90,738.89$

AMGN 5.00% $50,000.00 572.3443223 87.36$ 112.90$ 29% 64,617.67$

High Risk 5% $50,000.00

ILMN 1.00% $10,000.00 178.2531194 56.10$ 79.62$ 42% 14,192.51$

ONVO 1.00% $10,000.00 3745.318352 2.67$ 5.96$ 123% 22,322.10$

MJNA 1.00% $10,000.00 90909.09091 0.11$ 0.15$ 36% 13,636.36$

HMSY 1.00% $10,000.00 379.9392097 26.32$ 24.41$ -7% 9,274.32$

HEPI 1.00% $10,000.00 52631.57895 0.19$ 0.43$ 126% 22,631.58$

1,290,310.06$ Total

Portfolio Return (Not

Including Dividends) 29.03%


2/10

Last

Previous

Close High Low Volume Change % Change 52 Wk High 52 Wk Low Market Cap EPS P/E Ratio

WellPoint Inc Chart News 87.84 87.38 88.08 87.14 980,982 0.46 0.52% 90 53.69 26,251,708,685 9.18 9.57

UnitedHealth Group Inc Chart News 73.98 73.35 74.23 73.14 2,324,944 0.63 0.86% 74.23 51.09 75,235,779,576 5.26 14.07

Cigna Corp Chart News 81.3 80.34 81.75 80.31 1,075,200 0.96 1.19% 81.75 45.36 22,994,805,505 5.05 16.1

CVS Caremark Chart News 58.5 58.62 58.87 58.02 3,039,063 -0.12 -0.20% 62.36 44.33 71,871,894,647 3.37 17.34

Walgreen Co Chart News 50.23 49.49 50.6 49.82 3,931,208 0.74 1.50% 51.62 31.88 47,476,984,883 2.28 22

AmerisourceBergen Corp (Holding Co) Chart News 58.18 58.13 58.33 57.88 656,390 0.05 0.09% 59.75 37.12 13,435,097,921 2.44 23.89

McKesson Corp Chart News 122.96 123 123.45 122.53 375,511 -0.04 -0.03% 126.36 84.65 28,100,235,328 5.82 21.12

Cardinal Health Inc Chart News 50.21 50.24 50.78 50.17 1,267,379 -0.03 -0.06% 52.49 36.91 17,061,330,617 0.97 51.81

HCA Holdings Chart News 38.74 38.51 38.92 38.44 4,524,379 0.23 0.60% 41.83 27.92 17,326,798,871 3.12 12.41

Community Health Systems Inc Chart News 39.37 38.87 39.58 38.8 2,426,114 0.5 1.29% 51.29 26.33 3,735,100,579 2.35 16.75

Health Management Associates Inc Cl

A

Chart News 12.88 12.8 12.9 12.83 2,054,969 0.08 0.59% 17.28 6.97 3,348,962,790 0.47 27.1

Vanguard Health Systems Chart News 20.94 20.93 20.95 20.92 434,862 0.01 0.02% 20.97 7.84 1,631,118,560 0.75 27.91

Tenet Healthcare Corp Chart News 40.83 39.38 40.99 39.45 1,080,906 1.45 3.68% 49.48 5.17 4,145,605,992 -0.39 -105.85

Abbott Laboratories Chart News 33.72 33.46 33.73 33.49 3,796,139 0.26 0.78% 72.47 31.64 52,389,565,717 2.53 13.33

Eli Lilly & Co Chart News 52.09 52.18 52.35 51.92 1,707,206 -0.09 -0.17% 58.41 44.88 58,720,364,534 4.46 11.69

Merck & Co Inc Chart News 47.49 47.68 47.79 47.26 5,959,594 -0.2 -0.41% 50.16 40.02 138,915,046,504 1.68 28.23Pfizer Inc Chart News 28.24 28.37 28.53 28.16 16,242,135 -0.13 - 0.46% 31.15 23.55 186,890,403,300 1.52 18.62

Johnson & Johnson Chart News 86.95 86.9 87.17 86.62 4,508,715 0.05 0.06% 94.42 67.14 244,962,479,578 4.5 19.3

Intuitive Surgical Chart News 385.17 387.32 388.76 384.08 187,864 -2.15 -0.56% 585.67 357.02 15,277,274,071 17.18 22.39

Medtronic Inc Chart News 53.62 53.2 53.74 53.22 3,785,781 0.42 0.79% 55.98 40.28 5 4,098,250,347 3.37 15.93

iShares NASDAQ Biotechnology Index

Fund

Chart News 201.94 201.38 202.91 201.05 590,996 0.56 0.28% 202.91 125.63 3,706,883,500 0 0

Gilead Sciences Chart News 60.98 61.11 61.3 60.51 3,377,017 -0.14 -0.22% 79.37 39.21 93,613,087,444 1.78 34.2

Celgene Corporation Chart News 145.4 146.07 147.76 145.01 1,665,595 -0.67 -0.46% 149.92 70.66 59,927,027,271 3 .58 40.67

Amgen Inc Chart News 112.9 113.02 113.28 111.81 1,887,566 -0.12 -0.11% 116.25 80.6 85,121,718,055 5.93 19.04

Illumina Chart News 79.62 77.69 80.27 77.04 593,174 1.93 2.48% 83.23 41.74 10,005,908,857 0.85 94.52

Organovo Chart News 5.96 5.99 6.14 5.91 1,659,505 -0.03 -0.50% 8.5 1.8 457,229,196 -1.01 -5.35

HMS Holdings Corp Chart News 24.41 24.31 24.51 23.93 181,701 0.1 0.41% 35.73 18.5 2,146,882,764 0.54 45.24

Medical Marijuana I Chart News 0.15 0.15 0.16 0.14 11,714,670 -0.01 -4.22% 0 0 78,532,651 0 0

Health Enhancemt Prd Chart News 0.43 0.43 0.43 0.42 54,215 0 1.14% 0 0 47,529,953 -0.07 0

Symbol Lookup

Find stocks, mutual funds, options,

indices, and currencies.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where i

otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics.

provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

Stock Quotes Provided by MSN MoneyClick here to visit MSN Money

MSN Money Home Microsoft Office Tools on the Web

Discover MSN Money's tools,

columns, and more!

Get the latest from Microsoft Office

Terms of Use. 2013 Microsoft Corporation and/or its suppliers. All rights reserved.

DATA PROVIDERS

Copyright 2013 Microsoft. All rights reserved.
http://investing.money.msn.com/investments/stock-price?symbol=WLPhttp://investing.money.msn.com/investments/charts/?symbol=WLPhttp://money.msn.com/business-news/news.aspx?symbol=WLPhttp://investing.money.msn.com/investments/stock-price?symbol=UNHhttp://investing.money.msn.com/investments/charts/?symbol=UNHhttp://money.msn.com/business-news/news.aspx?symbol=UNHhttp://investing.money.msn.com/investments/stock-price?symbol=CIhttp://investing.money.msn.com/investments/charts/?symbol=CIhttp://money.msn.com/business-news/news.aspx?symbol=CIhttp://investing.money.msn.com/investments/stock-price?symbol=CVShttp://investing.money.msn.com/investments/charts/?symbol=CVShttp://money.msn.com/business-news/news.aspx?symbol=CVShttp://investing.money.msn.com/investments/stock-price?symbol=WAGhttp://investing.money.msn.com/investments/charts/?symbol=WAGhttp://money.msn.com/business-news/news.aspx?symbol=WAGhttp://investing.money.msn.com/investments/stock-price?symbol=ABChttp://investing.money.msn.com/investments/charts/?symbol=ABChttp://money.msn.com/business-news/news.aspx?symbol=ABChttp://investing.money.msn.com/investments/stock-price?symbol=MCKhttp://investing.money.msn.com/investments/charts/?symbol=MCKhttp://money.msn.com/business-news/news.aspx?symbol=MCKhttp://investing.money.msn.com/investments/stock-price?symbol=CAHhttp://investing.money.msn.com/investments/charts/?symbol=CAHhttp://money.msn.com/business-news/news.aspx?symbol=CAHhttp://investing.money.msn.com/investments/stock-price?symbol=HCAhttp://investing.money.msn.com/investments/charts/?symbol=HCAhttp://money.msn.com/business-news/news.aspx?symbol=HCAhttp://investing.money.msn.com/investments/stock-price?symbol=CYHhttp://investing.money.msn.com/investments/charts/?symbol=CYHhttp://money.msn.com/business-news/news.aspx?symbol=CYHhttp://investing.money.msn.com/investments/stock-price?symbol=HMAhttp://investing.money.msn.com/investments/stock-price?symbol=HMAhttp://investing.money.msn.com/investments/charts/?symbol=HMAhttp://money.msn.com/business-news/news.aspx?symbol=HMAhttp://investing.money.msn.com/investments/stock-price?symbol=VHShttp://investing.money.msn.com/investments/charts/?symbol=VHShttp://money.msn.com/business-news/news.aspx?symbol=VHShttp://investing.money.msn.com/investments/stock-price?symbol=THChttp://investing.money.msn.com/investments/charts/?symbol=THChttp://money.msn.com/business-news/news.aspx?symbol=THChttp://investing.money.msn.com/investments/stock-price?symbol=ABThttp://investing.money.msn.com/investments/charts/?symbol=ABThttp://money.msn.com/business-news/news.aspx?symbol=ABThttp://investing.money.msn.com/investments/stock-price?symbol=LLYhttp://investing.money.msn.com/investments/charts/?symbol=LLYhttp://money.msn.com/business-news/news.aspx?symbol=LLYhttp://investing.money.msn.com/investments/stock-price?symbol=MRKhttp://investing.money.msn.com/investments/charts/?symbol=MRKhttp://money.msn.com/business-news/news.aspx?symbol=MRKhttp://investing.money.msn.com/investments/stock-price?symbol=PFEhttp://investing.money.msn.com/investments/charts/?symbol=PFEhttp://money.msn.com/business-news/news.aspx?symbol=PFEhttp://investing.money.msn.com/investments/stock-price?symbol=JNJhttp://investing.money.msn.com/investments/charts/?symbol=JNJhttp://money.msn.com/business-news/news.aspx?symbol=JNJhttp://investing.money.msn.com/investments/stock-price?symbol=ISRGhttp://investing.money.msn.com/investments/charts/?symbol=ISRGhttp://money.msn.com/business-news/news.aspx?symbol=ISRGhttp://investing.money.msn.com/investments/stock-price?symbol=MDThttp://investing.money.msn.com/investments/charts/?symbol=MDThttp://money.msn.com/business-news/news.aspx?symbol=MDThttp://investing.money.msn.com/investments/stock-price?symbol=IBBhttp://investing.money.msn.com/investments/stock-price?symbol=IBBhttp://investing.money.msn.com/investments/charts/?symbol=IBBhttp://money.msn.com/business-news/news.aspx?symbol=IBBhttp://investing.money.msn.com/investments/stock-price?symbol=GILDhttp://investing.money.msn.com/investments/charts/?symbol=GILDhttp://money.msn.com/business-news/news.aspx?symbol=GILDhttp://investing.money.msn.com/investments/stock-price?symbol=CELGhttp://investing.money.msn.com/investments/charts/?symbol=CELGhttp://money.msn.com/business-news/news.aspx?symbol=CELGhttp://investing.money.msn.com/investments/stock-price?symbol=AMGNhttp://investing.money.msn.com/investments/charts/?symbol=AMGNhttp://money.msn.com/business-news/news.aspx?symbol=AMGNhttp://investing.money.msn.com/investments/stock-price?symbol=ILMNhttp://investing.money.msn.com/investments/charts/?symbol=ILMNhttp://money.msn.com/business-news/news.aspx?symbol=ILMNhttp://investing.money.msn.com/investments/stock-price?symbol=ONVOhttp://investing.money.msn.com/investments/charts/?symbol=ONVOhttp://money.msn.com/business-news/news.aspx?symbol=ONVOhttp://investing.money.msn.com/investments/stock-price?symbol=HMSYhttp://investing.money.msn.com/investments/charts/?symbol=HMSYhttp://money.msn.com/business-news/news.aspx?symbol=HMSYhttp://investing.money.msn.com/investments/stock-price?symbol=MJNAhttp://investing.money.msn.com/investments/charts/?symbol=MJNAhttp://money.msn.com/business-news/news.aspx?symbol=MJNAhttp://investing.money.msn.com/investments/stock-price?symbol=HEPIhttp://investing.money.msn.com/investments/charts/?symbol=HEPIhttp://money.msn.com/business-news/news.aspx?symbol=HEPIhttp://investing.money.msn.com/investments/find-symbolhttp://money.msn.com/http://money.msn.com/http://office.microsoft.com/http://g.msn.com/0TO_/enushttp://g.msn.com/0TO_/enushttp://office.microsoft.com/http://money.msn.com/http://money.msn.com/http://investing.money.msn.com/investments/find-symbolhttp://money.msn.com/business-news/news.aspx?symbol=HEPIhttp://investing.money.msn.com/investments/charts/?symbol=HEPIhttp://investing.money.msn.com/investments/stock-price?symbol=HEPIhttp://money.msn.com/business-news/news.aspx?symbol=MJNAhttp://investing.money.msn.com/investments/charts/?symbol=MJNAhttp://investing.money.msn.com/investments/stock-price?symbol=MJNAhttp://money.msn.com/business-news/news.aspx?symbol=HMSYhttp://investing.money.msn.com/investments/charts/?symbol=HMSYhttp://investing.money.msn.com/investments/stock-price?symbol=HMSYhttp://money.msn.com/business-news/news.aspx?symbol=ONVOhttp://investing.money.msn.com/investments/charts/?symbol=ONVOhttp://investing.money.msn.com/investments/stock-price?symbol=ONVOhttp://money.msn.com/business-news/news.aspx?symbol=ILMNhttp://investing.money.msn.com/investments/charts/?symbol=ILMNhttp://investing.money.msn.com/investments/stock-price?symbol=ILMNhttp://money.msn.com/business-news/news.aspx?symbol=AMGNhttp://investing.money.msn.com/investments/charts/?symbol=AMGNhttp://investing.money.msn.com/investments/stock-price?symbol=AMGNhttp://money.msn.com/business-news/news.aspx?symbol=CELGhttp://investing.money.msn.com/investments/charts/?symbol=CELGhttp://investing.money.msn.com/investments/stock-price?symbol=CELGhttp://money.msn.com/business-news/news.aspx?symbol=GILDhttp://investing.money.msn.com/investments/charts/?symbol=GILDhttp://investing.money.msn.com/investments/stock-price?symbol=GILDhttp://money.msn.com/business-news/news.aspx?symbol=IBBhttp://investing.money.msn.com/investments/charts/?symbol=IBBhttp://investing.money.msn.com/investments/stock-price?symbol=IBBhttp://investing.money.msn.com/investments/stock-price?symbol=IBBhttp://money.msn.com/business-news/news.aspx?symbol=MDThttp://investing.money.msn.com/investments/charts/?symbol=MDThttp://investing.money.msn.com/investments/stock-price?symbol=MDThttp://money.msn.com/business-news/news.aspx?symbol=ISRGhttp://investing.money.msn.com/investments/charts/?symbol=ISRGhttp://investing.money.msn.com/investments/stock-price?symbol=ISRGhttp://money.msn.com/business-news/news.aspx?symbol=JNJhttp://investing.money.msn.com/investments/charts/?symbol=JNJhttp://investing.money.msn.com/investments/stock-price?symbol=JNJhttp://money.msn.com/business-news/news.aspx?symbol=PFEhttp://investing.money.msn.com/investments/charts/?symbol=PFEhttp://investing.money.msn.com/investments/stock-price?symbol=PFEhttp://money.msn.com/business-news/news.aspx?symbol=MRKhttp://investing.money.msn.com/investments/charts/?symbol=MRKhttp://investing.money.msn.com/investments/stock-price?symbol=MRKhttp://money.msn.com/business-news/news.aspx?symbol=LLYhttp://investing.money.msn.com/investments/charts/?symbol=LLYhttp://investing.money.msn.com/investments/stock-price?symbol=LLYhttp://money.msn.com/business-news/news.aspx?symbol=ABThttp://investing.money.msn.com/investments/charts/?symbol=ABThttp://investing.money.msn.com/investments/stock-price?symbol=ABThttp://money.msn.com/business-news/news.aspx?symbol=THChttp://investing.money.msn.com/investments/charts/?symbol=THChttp://investing.money.msn.com/investments/stock-price?symbol=THChttp://money.msn.com/business-news/news.aspx?symbol=VHShttp://investing.money.msn.com/investments/charts/?symbol=VHShttp://investing.money.msn.com/investments/stock-price?symbol=VHShttp://money.msn.com/business-news/news.aspx?symbol=HMAhttp://investing.money.msn.com/investments/charts/?symbol=HMAhttp://investing.money.msn.com/investments/stock-price?symbol=HMAhttp://investing.money.msn.com/investments/stock-price?symbol=HMAhttp://money.msn.com/business-news/news.aspx?symbol=CYHhttp://investing.money.msn.com/investments/charts/?symbol=CYHhttp://investing.money.msn.com/investments/stock-price?symbol=CYHhttp://money.msn.com/business-news/news.aspx?symbol=HCAhttp://investing.money.msn.com/investments/charts/?symbol=HCAhttp://investing.money.msn.com/investments/stock-price?symbol=HCAhttp://money.msn.com/business-news/news.aspx?symbol=CAHhttp://investing.money.msn.com/investments/charts/?symbol=CAHhttp://investing.money.msn.com/investments/stock-price?symbol=CAHhttp://money.msn.com/business-news/news.aspx?symbol=MCKhttp://investing.money.msn.com/investments/charts/?symbol=MCKhttp://investing.money.msn.com/investments/stock-price?symbol=MCKhttp://money.msn.com/business-news/news.aspx?symbol=ABChttp://investing.money.msn.com/investments/charts/?symbol=ABChttp://investing.money.msn.com/investments/stock-price?symbol=ABChttp://money.msn.com/business-news/news.aspx?symbol=WAGhttp://investing.money.msn.com/investments/charts/?symbol=WAGhttp://investing.money.msn.com/investments/stock-price?symbol=WAGhttp://money.msn.com/business-news/news.aspx?symbol=CVShttp://investing.money.msn.com/investments/charts/?symbol=CVShttp://investing.money.msn.com/investments/stock-price?symbol=CVShttp://money.msn.com/business-news/news.aspx?symbol=CIhttp://investing.money.msn.com/investments/charts/?symbol=CIhttp://investing.money.msn.com/investments/stock-price?symbol=CIhttp://money.msn.com/business-news/news.aspx?symbol=UNHhttp://investing.money.msn.com/investments/charts/?symbol=UNHhttp://investing.money.msn.com/investments/stock-price?symbol=UNHhttp://money.msn.com/business-news/news.aspx?symbol=WLPhttp://investing.money.msn.com/investments/charts/?symbol=WLPhttp://investing.money.msn.com/investments/stock-price?symbol=WLP


3/10

# Shares Out

298,960,354

1,016,699,724

282,839,284

1,228,369,418

945,003,680230,903,118

228,624,484

339,461,413

447,200,900

94,811,539

260,214,669

77,932,086

101,607,990

1,554,125,355

1,126,637,846

2,926,375,532

6,620,299,8702,818,073,863

40,161,022

1,007,500,635

18,350,000

1,530,626,021

411,276,009

753,356,209

125,120,781

76,507,069

87,807,066

946,575,818

109,289,384

dicated

IPO data


4/10

Insurance

WLP UNH CI

Market Cap (intraday)5: 26.26B Market Cap (intraday)5: 75.22B Market Cap (intraday)5: 22.99B

Enterprise Value (Sep 5, 2013)3: 20.61B Enterprise Value (Sep 5, 2013)3: 80.27B Enterprise Value (Sep 5, 2013)3: 24.03B

Trailing P/E (ttm, intraday): 9.57 Trailing P/E (ttm, intraday): 14.09 Trailing P/E (ttm, intraday): 16.35Forward P/E (fye Dec 31, 2014)1: 10.39 Forward P/E (fye Dec 31, 2014)1: 12.67 Forward P/E (fye Dec 31, 2014)1: 11.21

PEG Ratio (5 yr expected)1: 0.91 PEG Ratio (5 yr expected)1: 1.48 PEG Ratio (5 yr expected)1: 1.11

Price/Sales (ttm): 0.39 Price/Sales (ttm): 0.64 Price/Sales (ttm): 0.73

Price/Book (mrq): 1.07 Price/Book (mrq): 2.35 Price/Book (mrq): 2.33

Enterprise Value/Revenue (ttm)3: 0.31 Enterprise Value/Revenue (ttm)3: 0.69 Enterprise Value/Revenue (ttm)3: 0.77

Enterprise Value/EBITDA (ttm)6: 3.63 Enterprise Value/EBITDA (ttm)6: 7.87 Enterprise Value/EBITDA (ttm)6: 6.46

Financial Highlights Fiscal Year Fiscal Year

Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec

Fiscal Year Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13

Fiscal Year Ends: 31-Dec

Most Recent Quarter (mrq): 30-Jun-13 Profitability Profitability

Profit Margin (ttm): 4.65% Profit Margin (ttm): 4.61%

Profitability Operating Margin (ttm): 7.92% Operating Margin (ttm): 10.74%

Profit Margin (ttm): 4.28%

Operating Margin (ttm): 7.32% Management Effectiveness Management Effectiveness

Return on Assets (ttm): 7.53% Return on Assets (ttm): 3.89%

Management Effectiveness Return on Equity (ttm): 17.80% Return on Equity (ttm): 15.22%

Return on Assets (ttm): 5.32%

Return on Equity (ttm): 11.79% Income Statement Income Statement

Revenue (ttm): 116.82B Revenue (ttm): 31.11B

Income Statement Revenue Per Share (ttm): 114.98 Revenue Per Share (ttm): 109.7

Revenue (ttm): 66.37B Qtrly Revenue Growth (yoy): 11.50% Qtrly Revenue Growth (yoy): 7.50%

Revenue Per Share (ttm): 216.55 Gross Profit (ttm): 30.39B Gross Profit (ttm): 11.22B

Qtrly Revenue Growth (yoy): 15.50% EBITDA (ttm)6: 10.20B EBITDA (ttm)6: 3.72B

Gross Profit (ttm): 13.50B Net Income Avl to Common (ttm): 5.43B Net Income Avl to Common (ttm): 1.43B

EBITDA (ttm)6: 5.68B Diluted EPS (ttm): 5.25 Diluted EPS (ttm): 4.97

Net Income Avl to Common (ttm): 2.84B Qtrly Earnings Growth (yoy): 7.40% Qtrly Earnings Growth (yoy): 32.90%

Diluted EPS (ttm): 9.17Qtrly Earnings Growth (yoy): 24.30% Balance Sheet Balance Sheet

Total Cash (mrq): 10.10B Total Cash (mrq): 3.51B

Balance Sheet Total Cash Per Share (mrq): 9.93 Total Cash Per Share (mrq): 12.41

Total Cash (mrq): 20.45B Total Debt (mrq): 16.72B Total Debt (mrq): 5.19B

Total Cash Per Share (mrq): 68.41 Total Debt/Equity (mrq): 52 Total Debt/Equity (mrq): 52.52

Total Debt (mrq): 15.51B Current Ratio (mrq): 0.68 Current Ratio (mrq): 1.07

Total Debt/Equity (mrq): 63.23 Book Value Per Share (mrq): 31.19 Book Value Per Share (mrq): 34.48

Current Ratio (mrq): 1.8

Book Value Per Share (mrq): 81.95 Cash Flow Statement Cash Flow Statement

Operating Cash Flow (ttm): 3.91B Operating Cash Flow (ttm): -250.00M

Cash Flow Statement Levered Free Cash Flow (ttm): 3.17B Levered Free Cash Flow (ttm): -374.25M

Operating Cash Flow (ttm): 2.38B

Levered Free Cash Flow (ttm): 2.24B


5/10

Drug Distributors

CVS WAG ABC MCK

Market Cap (intraday)5: 71.78B Market Cap (intraday)5: 47.48B Market Cap (intraday)5: 13.43B Market Cap (intraday)5: 28.11B

Enterprise Value (Sep 5, 2013)3: 79.34B Enterprise Value (Sep 5, 2013)3: 48.32B Enterprise Value (Sep 5, 2013)3: 13.02B Enterprise Value (Sep 5, 2013)3: 29.76B

Trailing P/E (ttm, intraday): 17.36 Trailing P/E (ttm, intraday): 21.98 Trailing P/E (ttm, intraday): 25.32 Trailing P/E (ttm, intraday): 21.12Forward P/E (fye Dec 31, 2014)1: 13.15 Forward P/E (fye Aug 31, 2014)1: 14.19 Forward P/E (fye Sep 30, 2014)1: 15.81 Forward P/E (fye Mar 31, 2015)1: 13.19

PEG Ratio (5 yr expected)1: 1.04 PEG Ratio (5 yr expected)1: 1.22 PEG Ratio (5 yr expected)1: 1.37 PEG Ratio (5 yr expected)1: 1.12

Price/Sales (ttm): 0.58 Price/Sales (ttm): 0.66 Price/Sales (ttm): 0.16 Price/Sales (ttm): 0.23

Price/Book (mrq): 1.85 Price/Book (mrq): 2.46 Price/Book (mrq): 5.55 Price/Book (mrq): 3.8

Enterprise Value/Revenue (ttm)3: 0.64 Enterprise Value/Revenue (ttm)3: 0.68 Enterprise Value/Revenue (ttm)3: 0.16 Enterprise Value/Revenue (ttm)3: 0.24

Enterprise Value/EBITDA (ttm)6: 8.24 Enterprise Value/EBITDA (ttm)6: 10.46 Enterprise Value/EBITDA (ttm)6: 10.23 Enterprise Value/EBITDA (ttm)6: 9.62

Fiscal Year Fiscal Year Fiscal Year Fiscal Year

Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Aug Fiscal Year Ends: 30-Sep Fiscal Year Ends: 31-Mar

Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 31-May-13 Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13

Profitability Profitability Profitability Profitability

Profit Margin (ttm): 3.41% Profit Margin (ttm): 3.01% Profit Margin (ttm): 0.65% Profit Margin (ttm): 1.12%

Operating Margin (ttm): 6.30% Operating Margin (ttm): 4.82% Operating Margin (ttm): 1.32% Operating Margin (ttm): 2.00%

Management Effectiveness Management Effectiveness Management Effectiveness Management Effectiveness

Return on Assets (ttm): 7.38% Return on Assets (ttm): 6.82% Return on Assets (ttm): 4.28% Return on Assets (ttm): 4.60%

Return on Equity (ttm): 10.98% Return on Equity (ttm): 12.62% Return on Equity (ttm): 21.70% Return on Equity (ttm): 18.88%

Income Statement Income Statement Income Statement Income Statement

Revenue (ttm): 123.63B Revenue (ttm): 71.35B Revenue (ttm): 83.96B Revenue (ttm): 123.96B

Revenue Per Share (ttm): 99.58 Revenue Per Share (ttm): 76.55 Revenue Per Share (ttm): 358.56 Revenue Per Share (ttm): 532.61

Qtrly Revenue Growth (yoy): 1.70% Qtrly Revenue Growth (yoy): 3.20% Qtrly Revenue Growth (yoy): 13.30% Qtrly Revenue Growth (yoy): 4.90%

Gross Profit (ttm): 22.51B Gross Profit (ttm): 20.34B Gross Profit (ttm): 2.67B Gross Profit (ttm): 6.98B

EBITDA (ttm)6: 9.63B EBITDA (ttm)6: 4.62B EBITDA (ttm)6: 1.27B EBITDA (ttm)6: 3.09B

Net Income Avl to Common (ttm): 4.22B Net Income Avl to Common (ttm): 2.15B Net Income Avl to Common (ttm): 580.15M Net Income Avl to Common (ttm): 1.38B

Diluted EPS (ttm): 3.37 Diluted EPS (ttm): 2.29 Diluted EPS (ttm): 2.3 Diluted EPS (ttm): 5.82

Qtrly Earnings Growth (yoy): 16.00% Qtrly Earnings Growth (yoy): 16.20% Qtrly Earnings Growth (yoy): -7.10% Qtrly Earnings Growth (yoy): 11.60%

Balance Sheet Balance Sheet Balance Sheet Balance Sheet

Total Cash (mrq): 1.18B Total Cash (mrq): 3.01B Total Cash (mrq): 1.57B Total Cash (mrq): 2.90B

Total Cash Per Share (mrq): 0.96 Total Cash Per Share (mrq): 3.18 Total Cash Per Share (mrq): 6.79 Total Cash Per Share (mrq): 12.71

Total Debt (mrq): 9.38B Total Debt (mrq): 6.37B Total Debt (mrq): 1.40B Total Debt (mrq): 4.87B

Total Debt/Equity (mrq): 24.1 Total Debt/Equity (mrq): 33.54 Total Debt/Equity (mrq): 57.75 Total Debt/Equity (mrq): 65.79

Current Ratio (mrq): 1.57 Current Ratio (mrq): 1.3 Current Ratio (mrq): 0.98 Current Ratio (mrq): 1.12

Book Value Per Share (mrq): 31.71 Book Value Per Share (mrq): 20.08 Book Value Per Share (mrq): 10.48 Book Value Per Share (mrq): 32.4

Cash Flow Statement Cash Flow Statement Cash Flow Statement Cash Flow Statement

Operating Cash Flow (ttm): 5.20B Operating Cash Flow (ttm): 3.95B Operating Cash Flow (ttm): 1.36B Operating Cash Flow (ttm): 3.75B

Levered Free Cash Flow (ttm): 3.01B Levered Free Cash Flow (ttm): 2.44B Levered Free Cash Flow (ttm): 1.46B Levered Free Cash Flow (ttm): 2.17B


6/10

Hospitals

HCA CYH HMA VHS



Trailing P/E (ttm, intraday): 12.42 Trailing P/E (ttm, intraday): 16.8 Trailing P/E (ttm, intraday): 27.62 Trailing P/E (ttm, intraday): 27.87Forward P/E (fye Dec 31, 2014)1: 10.28 Forward P/E (fye Dec 31, 2014)1: 10.18 Forward P/E (fye Dec 31, 2014)1: 16.5 Forward P/E (fye Jun 30, 2015)1: 20.72

PEG Ratio (5 yr expected)1: 1.02 PEG Ratio (5 yr expected)1: 1.26 PEG Ratio (5 yr expected)1: 1.91 PEG Ratio (5 yr expected)1: 3.33


Price/Book (mrq): N/A Price/Book (mrq): 1.22 Price/Book (mrq): 3.07 Price/Book (mrq): 4.15

Enterprise Value/Revenue (ttm)3: 1.35 Enterprise Value/Revenue (ttm)3: 1 Enterprise Value/Revenue (ttm)3: 1.2 Enterprise Value/Revenue (ttm)3: 0.67



Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec Fiscal Year Ends: 30-Jun

Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13






Return on Equity (ttm): N/A Return on Equity (ttm): 8.96% Return on Equity (ttm): 14.43% Return on Equity (ttm): 16.78%




Qtrly Revenue Growth (yoy): 4.20% Qtrly Revenue Growth (yoy): -0.20% Qtrly Revenue Growth (yoy): -0.50% Qtrly Revenue Growth (yoy): N/A


EBITDA (ttm)6: 6.36B EBITDA (ttm)6: 1.71B EBITDA (ttm)6: 882.06M EBITDA (ttm)6: 525.30M

Net Income Avl to Common (ttm): 1.44B Net Income Avl to Common (ttm): 215.73M Net Income Avl to Common (ttm): 123.30M Net Income Avl to Common (ttm): 59.80M


Qtrly Earnings Growth (yoy): 8.20% Qtrly Earnings Growth (yoy): -64.30% Qtrly Earnings Growth (yoy): -80.10% Qtrly Earnings Growth (yoy): N/A


Total Cash (mrq): 528.00M Total Cash (mrq): 251.23M Total Cash (mrq): 85.91M Total Cash (mrq): 624.00M



Total Debt/Equity (mrq): N/A Total Debt/Equity (mrq): 283.79 Total Debt/Equity (mrq): 341.1 Total Debt/Equity (mrq): 640.49


Book Value Per Share (mrq): -19.74 Book Value Per Share (mrq): 31.79 Book Value Per Share (mrq): 4.17 Book Value Per Share (mrq): 5.05


Operating Cash Flow (ttm): 3.47B Operating Cash Flow (ttm): 1.11B Operating Cash Flow (ttm): 432.62M Operating Cash Flow (ttm): 300.80M

Levered Free Cash Flow (ttm): 1.29B Levered Free Cash Flow (ttm): 225.36M Levered Free Cash Flow (ttm): 70.53M Levered Free Cash Flow (ttm): 29.27M


7/10

Pharmaceuticals

ABT LLY MRK PFE



Trailing P/E (ttm, intraday): 13.45 Trailing P/E (ttm, intraday): 11.71 Trailing P/E (ttm, intraday): 28.43 Trailing P/E (ttm, intraday): 7.83Forward P/E (fye Dec 31, 2014)1: 15.12 Forward P/E (fye Dec 31, 2014)1: 18.82 Forward P/E (fye Dec 31, 2014)1: 12.9 Forward P/E (fye Dec 31, 2014)1: 12.27

PEG Ratio (5 yr expected)1: 1.4 PEG Ratio (5 yr expected)1: -3.43 PEG Ratio (5 yr expected)1: 5.02 PEG Ratio (5 yr expected)1: 4.29


Price/Book (mrq): 2.33 Price/Book (mrq): 3.7 Price/Book (mrq): 2.94 Price/Book (mrq): 2.39

Enterprise Value/Revenue (ttm)3: 1.27 Enterprise Value/Revenue (ttm)3: 2.45 Enterprise Value/Revenue (ttm)3: 3.29 Enterprise Value/Revenue (ttm)3: 3.35



Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec

Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13






Return on Equity (ttm): 26.48% Return on Equity (ttm): 33.23% Return on Equity (ttm): 9.77% Return on Equity (ttm): 14.04%




Qtrly Revenue Growth (yoy): 2.50% Qtrly Revenue Growth (yoy): 5.90% Qtrly Revenue Growth (yoy): -10.60% Qtrly Revenue Growth (yoy): -7.10%


EBITDA (ttm)6: 11.54B EBITDA (ttm)6: 6.88B EBITDA (ttm)6: 15.29B EBITDA (ttm)6: 24.60B

Net Income Avl to Common (ttm): 6.19B Net Income Avl to Common (ttm): 4.91B Net Income Avl to Common (ttm): 5.14B Net Income Avl to Common (ttm): 11.09B


Qtrly Earnings Growth (yoy): -72.40% Qtrly Earnings Growth (yoy): 30.60% Qtrly Earnings Growth (yoy): -49.50% Qtrly Earnings Growth (yoy): 333.30%


Total Cash (mrq): 9.39B Total Cash (mrq): 4.72B Total Cash (mrq): 18.10B Total Cash (mrq): 33.78B



Total Debt/Equity (mrq): 35.38 Total Debt/Equity (mrq): 34.88 Total Debt/Equity (mrq): 56.16 Total Debt/Equity (mrq): 46.78




Operating Cash Flow (ttm): 6.20B Operating Cash Flow (ttm): 5.16B Operating Cash Flow (ttm): 9.63B Operating Cash Flow (ttm): 16.33B

Levered Free Cash Flow (ttm): 6.88B Levered Free Cash Flow (ttm): 3.84B Levered Free Cash Flow (ttm): 8.99B Levered Free Cash Flow (ttm): 18.09B


8/10

Medical Devices

ISRG MDT

Market Cap (intraday)5: 15.28B Market Cap (intraday)5: 54.14B

Enterprise Value (Sep 5, 2013)3: 13.98B Enterprise Value (Sep 5, 2013)3: 52.18B

Trailing P/E (ttm, intraday): 22.37 Trailing P/E (ttm, intraday): 15.48Forward P/E (fye Dec 31, 2014)1: 22.05 Forward P/E (fye Apr 26, 2015)1: 13.1

PEG Ratio (5 yr expected)1: 1.85 PEG Ratio (5 yr expected)1: 2.15

Price/Sales (ttm): 6.58 Price/Sales (ttm): 3.22

Price/Book (mrq): 4.13 Price/Book (mrq): 2.9

Enterprise Value/Revenue (ttm)3: 5.98 Enterprise Value/Revenue (ttm)3: 3.13

Enterprise Value/EBITDA (ttm)6: 14.09 Enterprise Value/EBITDA (ttm)6: 9.26

Fiscal Year Fiscal Year

Fiscal Year Ends: 31-Dec Fiscal Year Ends: 26-Apr

Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 26-Jul-13

Profitability Profitability

Profit Margin (ttm): 30.22% Profit Margin (ttm): 21.34%

Operating Margin (ttm): 39.76% Operating Margin (ttm): 28.85%

Management Effectiveness Management Effectiveness

Return on Assets (ttm): 14.84% Return on Assets (ttm): 8.82%

Return on Equity (ttm): 20.47% Return on Equity (ttm): 19.88%

Income Statement Income Statement

Revenue (ttm): 2.34B Revenue (ttm): 16.66B

Revenue Per Share (ttm): 58.43 Revenue Per Share (ttm): 16.43

Qtrly Revenue Growth (yoy): 7.80% Qtrly Revenue Growth (yoy): 1.90%

Gross Profit (ttm): 1.57B Gross Profit (ttm): 12.46B

EBITDA (ttm)6: 992.40M EBITDA (ttm)6: 5.64B

Net Income Avl to Common (ttm): 706.20M Net Income Avl to Common (ttm): 3.56B

Diluted EPS (ttm): 17.19 Diluted EPS (ttm): 3.47

Qtrly Earnings Growth (yoy): 2.70% Qtrly Earnings Growth (yoy): 10.30%

Balance Sheet Balance Sheet

Total Cash (mrq): 1.29B Total Cash (mrq): 11.33B

Total Cash Per Share (mrq): 32.49 Total Cash Per Share (mrq): 11.22

Total Debt (mrq): 0 Total Debt (mrq): 11.18B

Total Debt/Equity (mrq): N/A Total Debt/Equity (mrq): 60.37

Current Ratio (mrq): 4.76 Current Ratio (mrq): 4.25

Book Value Per Share (mrq): 93.67 Book Value Per Share (mrq): 18.34

Cash Flow Statement Cash Flow Statement

Operating Cash Flow (ttm): 885.50M Operating Cash Flow (ttm): 4.58B

Levered Free Cash Flow (ttm): 643.45M Levered Free Cash Flow (ttm): 3.67B


9/10

Biotechnology

GILD CELG AMGN

Market Cap (intraday)5: 93.33B Market Cap (intraday)5: 59.81B Market Cap (intraday)5: 85.05B

Enterprise Value (Sep 5, 2013)3: 97.30B Enterprise Value (Sep 5, 2013)3: 58.22B Enterprise Value (Sep 5, 2013)3: 83.91B

Trailing P/E (ttm, intraday): 34.25 Trailing P/E (ttm, intraday): 40.75 Trailing P/E (ttm, intraday): 19.04Forward P/E (fye Dec 31, 2014)1: 20.4 Forward P/E (fye Dec 31, 2014)1: 20.21 Forward P/E (fye Dec 31, 2014)1: 13.79

PEG Ratio (5 yr expected)1: 1.13 PEG Ratio (5 yr expected)1: 1.08 PEG Ratio (5 yr expected)1: 1.69

Price/Sales (ttm): 9.07 Price/Sales (ttm): 10.13 Price/Sales (ttm): 4.82

Price/Book (mrq): 8.42 Price/Book (mrq): 11.11 Price/Book (mrq): 4.13

Enterprise Value/Revenue (ttm)3: 9.43 Enterprise Value/Revenue (ttm)3: 9.82 Enterprise Value/Revenue (ttm)3: 4.75

Enterprise Value/EBITDA (ttm)6: 21.87 Enterprise Value/EBITDA (ttm)6: 23.28 Enterprise Value/EBITDA (ttm)6: 11.88

Fiscal Year Fiscal Year Fiscal Year

Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec Fiscal Year Ends: 31-Dec

Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13

Profitability Profitability Profitability

Profit Margin (ttm): 28.44% Profit Margin (ttm): 26.14% Profit Margin (ttm): 25.98%

Operating Margin (ttm): 40.31% Operating Margin (ttm): 36.41% Operating Margin (ttm): 33.70%

Management Effectiveness Management Effectiveness Management Effectiveness

Return on Assets (ttm): 12.05% Return on Assets (ttm): 12.08% Return on Assets (ttm): 7.10%

Return on Equity (ttm): 30.01% Return on Equity (ttm): 27.28% Return on Equity (ttm): 23.03%

Income Statement Income Statement Income Statement

Revenue (ttm): 10.31B Revenue (ttm): 5.93B Revenue (ttm): 17.66B

Revenue Per Share (ttm): 6.79 Revenue Per Share (ttm): 14.11 Revenue Per Share (ttm): 23.25

Qtrly Revenue Growth (yoy): 15.10% Qtrly Revenue Growth (yoy): 17.00% Qtrly Revenue Growth (yoy): 4.50%

Gross Profit (ttm): 7.23B Gross Profit (ttm): 5.21B Gross Profit (ttm): 14.35B

EBITDA (ttm)6: 4.45B EBITDA (ttm)6: 2.50B EBITDA (ttm)6: 7.06B

Net Income Avl to Common (ttm): 2.93B Net Income Avl to Common (ttm): 1.55B Net Income Avl to Common (ttm): 4.59B

Diluted EPS (ttm): 1.79 Diluted EPS (ttm): 3.58 Diluted EPS (ttm): 5.93

Qtrly Earnings Growth (yoy): 8.60% Qtrly Earnings Growth (yoy): 30.10% Qtrly Earnings Growth (yoy): -0.60%

Balance Sheet Balance Sheet Balance Sheet

Total Cash (mrq): 2.29B Total Cash (mrq): 4.08B Total Cash (mrq): 22.02B

Total Cash Per Share (mrq): 1.49 Total Cash Per Share (mrq): 9.92 Total Cash Per Share (mrq): 29.23

Total Debt (mrq): 7.34B Total Debt (mrq): 3.67B Total Debt (mrq): 23.92B

Total Debt/Equity (mrq): 64.69 Total Debt/Equity (mrq): 67.8 Total Debt/Equity (mrq): 116.13

Current Ratio (mrq): 1.43 Current Ratio (mrq): 2.62 Current Ratio (mrq): 6.2

Book Value Per Share (mrq): 7.26 Book Value Per Share (mrq): 13.15 Book Value Per Share (mrq): 27.35

Cash Flow Statement Cash Flow Statement Cash Flow Statement

Operating Cash Flow (ttm): 3.08B Operating Cash Flow (ttm): 2.16B Operating Cash Flow (ttm): 5.18B

Levered Free Cash Flow (ttm): 2.28B Levered Free Cash Flow (ttm): 1.81B Levered Free Cash Flow (ttm): 2.46B


10/10

High Risk

ILMN ONVO MJNA HMSY

Market Cap (intraday)5: 9.96B Market Cap (intraday)5: 455.22M Market Cap (intraday)5: 138.06M Market Cap (intraday)5: 2.14B

Enterprise Value (Sep 5, 2013)3: 9.46B Enterprise Value (Sep 5, 2013)3: 424.03M Enterprise Value (Sep 5, 2013)3: 135.00M Enterprise Value (Sep 5, 2013)3: 2.37B

Trailing P/E (ttm, intraday): 94.12 Trailing P/E (ttm, intraday): 39.6 Trailing P/E (ttm, intraday): N/A Trailing P/E (ttm, intraday): 45.28Forward P/E (fye Dec 30, 2014)1: 39.41 Forward P/E (fye Mar 31, 2015)1: N/A Forward P/E (fye )1: N/A Forward P/E (fye Dec 31, 2014)1: 22.64

PEG Ratio (5 yr expected)1: 2.66 PEG Ratio (5 yr expected)1: N/A PEG Ratio (5 yr expected)1: N/A PEG Ratio (5 yr expected)1: 1.42

Price/Sales (ttm): 7.64 Price/Sales (ttm): 402.35 Price/Sales (ttm): N/A Price/Sales (ttm): 4.37

Price/Book (mrq): 7 Price/Book (mrq): 56.51 Price/Book (mrq): 4.97 Price/Book (mrq): 4.31

Enterprise Value/Revenue (ttm)3: 7.44 Enterprise Value/Revenue (ttm)3: 372.28 Enterprise Value/Revenue (ttm)3: NaN Enterprise Value/Revenue (ttm)3: 4.84

Enterprise Value/EBITDA (ttm)6: 27.26 Enterprise Value/EBITDA (ttm)6: -39.38 Enterprise Value/EBITDA (ttm)6: N/A Enterprise Value/EBITDA (ttm)6: 15.84


Fiscal Year Ends: 30-Dec Fiscal Year Ends: 31-Mar Fiscal Year Ends: N/A Fiscal Year Ends: 31-Dec

Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 30-Jun-13 Most Recent Quarter (mrq): 31-Mar-13 Most Recent Quarter (mrq): 30-Jun-13


Profit Margin (ttm): 9.04% Profit Margin (ttm): 792.06% Profit Margin (ttm): N/A Profit Margin (ttm): 9.80%

Operating Margin (ttm): 21.21% Operating Margin (ttm): -974.44% Operating Margin (ttm): N/A Operating Margin (ttm): 18.66%


Return on Assets (ttm): 6.52% Return on Assets (ttm): N/A Return on Assets (ttm): N/A Return on Assets (ttm): 6.36%

Return on Equity (ttm): 8.95% Return on Equity (ttm): N/A Return on Equity (ttm): N/A Return on Equity (ttm): 10.45%


Revenue (ttm): 1.27B Revenue (ttm): 1.14M Revenue (ttm): N/A Revenue (ttm): 488.73M

Revenue Per Share (ttm): 10.3 Revenue Per Share (ttm): 0.02 Revenue Per Share (ttm): N/A Revenue Per Share (ttm): 5.62

Qtrly Revenue Growth (yoy): 23.30% Qtrly Revenue Growth (yoy): -59.10% Qtrly Revenue Growth (yoy): -6.80% Qtrly Revenue Growth (yoy): 4.80%

Gross Profit (ttm): 773.53M Gross Profit (ttm): 1.20M Gross Profit (ttm): N/A Gross Profit (ttm): 154.79M

EBITDA (ttm)6: 347.06M EBITDA (ttm)6: -10.77M EBITDA (ttm)6: N/A EBITDA (ttm)6: 149.34M

Net Income Avl to Common (ttm): 114.94M Net Income Avl to Common (ttm): 9.02M Net Income Avl to Common (ttm): N/A Net Income Avl to Common (ttm): 47.89M

Diluted EPS (ttm): 0.85 Diluted EPS (ttm): 0.15 Diluted EPS (ttm): N/A Diluted EPS (ttm): 0.54

Qtrly Earnings Growth (yoy): 53.30% Qtrly Earnings Growth (yoy): N/A Qtrly Earnings Growth (yoy): 344.50% Qtrly Earnings Growth (yoy): -19.70%


Total Cash (mrq): 1.13B Total Cash (mrq): 12.85M Total Cash (mrq): 14.76M Total Cash (mrq): 131.47M


Total Debt (mrq): 851.90M Total Debt (mrq): 22.00K Total Debt (mrq): 0 Total Debt (mrq): 302.80M

Total Debt/Equity (mrq): 61.35 Total Debt/Equity (mrq): 0.32 Total Debt/Equity (mrq): N/A Total Debt/Equity (mrq): 61.12

Current Ratio (mrq): 3.93 Current Ratio (mrq): 1.75 Current Ratio (mrq): N/A Current Ratio (mrq): 5



Operating Cash Flow (ttm): 306.55M Operating Cash Flow (ttm): -9.69M Operating Cash Flow (ttm): N/A Operating Cash Flow (ttm): 82.29M

Levered Free Cash Flow (ttm): 241.88M Levered Free Cash Flow (ttm): N/A Levered Free Cash Flow (ttm): N/A Levered Free Cash Flow (ttm): 74.76M

Documents

ACA Portfolio, Winners and Losers Affordable Care Act (ObamaCare)